SAN FRANCISCO, Sept. 22, 2015 /PRNewswire/ -- Invuity, Inc.
(NASDAQ: IVTY), a leading medical technology company, today
announced the introduction of its Eiberg™ Illuminated Retractor
System. This latest innovation adds to the company's portfolio of
orthopedic products including the Saber Yankauer™ Illuminated
Aspiration System and Eivector™ Illuminated Retractor System. This
product portfolio enables superior intracavity illumination and
visualization, supporting the growing trend in orthopedic surgery
toward less invasive procedures.
Eiberg™ was designed to address the unmet need for illumination
and visualization of the dark surgical cavities encountered by
surgeons during total hip replacement surgery and hip and pelvic
trauma. The combination of its ergonomic design, atraumatic blade,
and integrated Intelligent Photonics™ facilitates simultaneous
tissue retraction and broad, volumetric, thermally cool
illumination of the surgical target. Additionally, the blade tip
design facilitates secure anchoring to bone, ensuring maximum
utility during orthopedic procedures.
"With our commitment to advancing the standard of care for
surgical interventions, we are pleased to announce the release of
Eiberg™, which broadens our orthopedic portfolio," said Invuity CEO
Philip Sawyer. "Feedback from
surgeons is very positive, and we anticipate a full commercial
launch in October as we continue to expand the number of products
designed to enable less invasive procedures in orthopedic
surgery."
Orthopedic surgeons continue to express to Invuity the need for
and value of improved illumination and visualization during
procedures such as anterior approach to total hip arthroplasty.
Last week, Charles DeCook, M.D.,
Joint Surgeon Specialists, Northside Hospital, Atlanta, GA, demonstrated and featured the
Saber Yankauer™ during an anterior approach total hip replacement
surgery that was live-streamed to hundreds of surgeon attendees at
the International Congress for Joint Reconstruction (ICJR) Combined
OrthoLIVE/MTJR Course.
"Invuity's Intelligent Photonics™ devices offer much needed
innovation in less invasive surgical techniques, especially when
used in a procedure such as an anterior approach to total hip
arthroplasty," said Dr. DeCook. "The Saber Yankauer delivers
significantly improved illumination and visualization of the
surgical cavity enabling me to perform the procedure with greater
precision, efficiency and safety. It has become a standard of care
in my clinical practice today and I look forward incorporating
Invuity's latest innovations into my surgical armamentarium."
Invuity's Intelligent Photonics™ products will continue to gain
broad exposure in orthopedic surgery as they will be showcased at
this week's ICJR 4th Annual Anterior Hip Course, a
gathering for the world's leading joint replacement surgeons, in
Houston, TX (September 24-26).
About Invuity®
Invuity, Inc. is a medical technology company focused on
developing and marketing advanced photonics devices to improve the
ability of surgeons to illuminate and visualize the surgical cavity
during open minimally invasive and minimal access surgery. The
company's patented Intelligent Photonics™ technology enables
enhanced surgical precision, efficiency and safety by providing
superior visualization. Clinical applications include breast and
thyroid oncology, plastic reconstructive, spine, orthopedic,
cardiothoracic and general surgery among
others. Invuity is headquartered in San Francisco,
CA. For more information, visit www.invuity.com.
Forward-Looking Statements
This announcement contains forward-looking statements that
involve risks and uncertainties, including statements regarding
market opportunities and potential results from future new
initiatives. Actual results could differ materially from those
projected in the forward-looking statements as a result of certain
risk factors, including, but not limited to: fluctuations in demand
or failure to gain market acceptance for the Company's devices; the
Company's ability to demonstrate to and gain approval from
hospitals to use the Company's devices; the highly competitive
business environment for surgical medical devices; the Company's
ability to sell its devices at prices that support its current
business strategies; difficulty forecasting future financial
performance; protection of the Company's intellectual property; and
compliance with necessary regulatory clearances or approvals. The
Company undertakes no obligation to update the forward-looking
information in this release. More information about potential
factors that could affect the Company's business and financial
results is included in its filings with the Securities and Exchange
Commission, including, without limitation, under the captions:
"Management's Discussion and Analysis of Financial Condition and
Results of Operations," and "Risk Factors," which are on file with
the Securities and Exchange Commission.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/invuity-introduces-eiberg-illuminated-retractor-system-with-integrated-intelligent-photonics-to-orthopedic-market-300146937.html
SOURCE Invuity, Inc.